NASDAQ: LRMRLarimar Therapeutics Inc Stock Ownership - Who owns Larimar Therapeutics?
Insider buying vs selling
Have Larimar Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LRMR insiders and whales buy or sell their stock.
LRMR Shareholders
What type of owners hold Larimar Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 44.96% | 28,789,915 | $54.99M | Insider |
| Deerfield Management Company LP Series C | 33.16% | 21,231,974 | $40.55M | Institution |
| Peter Barrett | 16.05% | 10,276,057 | $19.63M | Insider |
| Bruce Booth | 16.04% | 10,270,758 | $19.62M | Insider |
| Janus Henderson Group PLC | 10.06% | 6,443,286 | $12.31M | Institution |
| Ra Capital Management LP | 9.44% | 6,045,351 | $11.55M | Institution |
| Blue Owl Capital Holdings LP | 7.27% | 4,653,040 | $8.89M | Institution |
| Goldman Sachs Group Inc | 6.49% | 4,152,228 | $7.93M | Institution |
| Blackrock Inc | 5.10% | 3,265,905 | $6.24M | Institution |
| Deerfield Partners LP | 4.34% | 2,777,777 | $5.31M | Insider |
LRMR vs Biotech Stocks
Larimar Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.